1. Stocks
  2. Eton Pharmaceuticals Inc
  3. Swot
swot-logo

Eton Pharmaceuticals Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Eton Pharmaceuticals Inc has 18 Strengths, 11 Weaknesses, 2 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

MACD Crossover Above Signal Line

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Companies with 10% increase in share price over three months, with rising net profit growth

Consistent Highest Return Stocks over Five Years - Nifty500

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over Half Year (6 Months)

Relative Outperformance versus Industry over the Quarter (3 Months)

Relative Outperformance versus Industry over 1 Year

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

MACD crossed above signal line previous end of day

Company with Low Debt

Increasing Revenue every Quarter for the past 4 Quarters

Stock with Low PE (PE < = 10)

Volume Shockers

Highest Recovery from 52 Week Low

Stocks Outperforming their Industry Price Change in the Quarter

Negative Breakdown First Support (LTP < S1)

Momentum Trap (DVM)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Low durability companies

High Volume, Top Losers

High volume, top losers

Top Losers

Negative Breakdown First Support (LTP < S1)

Low Piotroski Score : Companies with weak financials

Declining Net Cash Flow : Companies not able to generate net cash

Top Losers

Forecaster Consensus Estimates: Stocks with Strong Buy Calls from Analysts

Institutions increasing their shareholding

Mutual Funds Decreased Shareholding in Past Month

MFs decreased their shareholding last quarter

Promoters increasing shareholding QoQ

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks